BRIEF-Venaxis reports acquisition of Bioptix

* Acquired as of Sept 12, approximately 98% of voting shares of Bioptix for about 14% of Venaxis post-deal outstanding common shares Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.